State Street’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.05M Buy
1,056,585
+35,204
+3% +$135K ﹤0.01% 3034
2025
Q1
$5.87M Sell
1,021,381
-11,992
-1% -$69K ﹤0.01% 2812
2024
Q4
$5.16M Buy
1,033,373
+59,465
+6% +$297K ﹤0.01% 2958
2024
Q3
$5.25M Buy
973,908
+16,188
+2% +$87.3K ﹤0.01% 2951
2024
Q2
$3.17M Buy
957,720
+18,151
+2% +$60.1K ﹤0.01% 3119
2024
Q1
$3.07M Buy
939,569
+40,560
+5% +$133K ﹤0.01% 3123
2023
Q4
$3.16M Sell
899,009
-2,166,958
-71% -$7.61M ﹤0.01% 3153
2023
Q3
$20.5M Buy
3,065,967
+24,101
+0.8% +$161K ﹤0.01% 2167
2023
Q2
$25.5M Buy
3,041,866
+2,868,585
+1,655% +$24.1M ﹤0.01% 2089
2023
Q1
$1.72M Hold
173,281
﹤0.01% 3386
2022
Q4
$1.21M Sell
173,281
-600
-0.3% -$4.18K ﹤0.01% 3519
2022
Q3
$929K Hold
173,881
﹤0.01% 3611
2022
Q2
$694K Sell
173,881
-703,916
-80% -$2.81M ﹤0.01% 3718
2022
Q1
$3.9M Sell
877,797
-2,204,555
-72% -$9.8M ﹤0.01% 3300
2021
Q4
$12.3M Sell
3,082,352
-345,027
-10% -$1.38M ﹤0.01% 2792
2021
Q3
$30.1M Buy
3,427,379
+294,240
+9% +$2.58M ﹤0.01% 2180
2021
Q2
$35.5M Buy
3,133,139
+710,115
+29% +$8.05M ﹤0.01% 2104
2021
Q1
$28.8M Buy
2,423,024
+2,402,324
+11,605% +$28.5M ﹤0.01% 2128
2020
Q4
$142K Buy
20,700
+1,600
+8% +$11K ﹤0.01% 3787
2020
Q3
$142K Hold
19,100
﹤0.01% 3687
2020
Q2
$80K Sell
19,100
-383,909
-95% -$1.61M ﹤0.01% 3672
2020
Q1
$995K Sell
403,009
-14,198
-3% -$35.1K ﹤0.01% 3308
2019
Q4
$2.42M Buy
417,207
+18,351
+5% +$107K ﹤0.01% 3186
2019
Q3
$2.1M Sell
398,856
-352
-0.1% -$1.86K ﹤0.01% 3199
2019
Q2
$2.4M Buy
399,208
+44,006
+12% +$264K ﹤0.01% 3170
2019
Q1
$3.21M Buy
355,202
+70,722
+25% +$639K ﹤0.01% 2967
2018
Q4
$2.36M Buy
284,480
+37,690
+15% +$313K ﹤0.01% 3055
2018
Q3
$3.41M Buy
246,790
+10,164
+4% +$140K ﹤0.01% 3046
2018
Q2
$1.88M Buy
236,626
+210,695
+813% +$1.67M ﹤0.01% 3291
2018
Q1
$194K Buy
25,931
+3,262
+14% +$24.4K ﹤0.01% 3560
2017
Q4
$155K Buy
22,669
+4,169
+23% +$28.5K ﹤0.01% 3585
2017
Q3
$133K Buy
+18,500
New +$133K ﹤0.01% 3624